These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19393492)

  • 1. The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus.
    Ray A; Huisman MV; Tamsma JT; ; van Asten J; Bingen BO; Broeders EA; Hoogeveen ES; van Hout F; Kwee VA; Laman B; Malgo F; Mohammadi M; Nijenhuis M; Rijkée M; van Tellingen MM; Tromp M; Tummers Q; de Vries L
    Eur J Intern Med; 2009 May; 20(3):253-60. PubMed ID: 19393492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ; Juonala M; Raitakari OT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Aso Y; Mittermayer F; Inukai T; Brix J; Schernthaner G
    Transl Res; 2009 Apr; 153(4):199-203. PubMed ID: 19304279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
    Johansen OE
    Scand J Clin Lab Invest; 2007; 67(8):786-800. PubMed ID: 17852797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P; Ghanim H; Chaudhuri A; Mohanty P
    J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections.
    Moutsopoulos NM; Madianos PN
    Ann N Y Acad Sci; 2006 Nov; 1088():251-64. PubMed ID: 17192571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular manifestations of rheumatic diseases.
    Goodson NJ; Solomon DH
    Curr Opin Rheumatol; 2006 Mar; 18(2):135-40. PubMed ID: 16462518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and oral disease interactions: what is the evidence?
    Ford PJ; Yamazaki K; Seymour GJ
    Prim Dent Care; 2007 Apr; 14(2):59-66. PubMed ID: 17462139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Chryssohoou E; Kyrkou K; Georgiopoulos G; Protogerou A; Panoulas VF; Sandoo A; Tentolouris N; Mavrikakis M; Sfikakis PP
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1702-8. PubMed ID: 19608975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials?
    Mangoni AA
    Clin Chim Acta; 2006 May; 367(1-2):11-9. PubMed ID: 16413521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
    Ryan S; Taylor CT; McNicholas WT
    Thorax; 2009 Jul; 64(7):631-6. PubMed ID: 19561283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The link between periodontal disease and cardiovascular disease is probably inflammation.
    Davé S; Van Dyke T
    Oral Dis; 2008 Mar; 14(2):95-101. PubMed ID: 18302669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between periodontal diseases and cardiovascular diseases: a narrative review.
    Guiglia R; Lo Russo L; Coccia E; Di Liberto C; D'Angelo M; Indovina G; Lo Muzio L; Campisi G
    Panminerva Med; 2008 Dec; 50(4):327-37. PubMed ID: 19078873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes.
    Ramachandran S; Kartha CC
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1005-15. PubMed ID: 22647032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.